Merck Secures 2 Patents in India for Obesity and Dyslipidemia Drugs

by Thilaka on  May 12, 2008 at 4:40 PM Drug News
  •   Print
  •   Share
  •   Comments
  •  Text 
US-based Merck has received patent approval for two of its upcoming drugs for dyslipidemia and obesity from the Indian Patent Office. The two newly patented drugs that are in the final stages of trial and are yet to receive the Drug Controller General of India’s (DCGI) approval.

Up until now, Januvia, Merck’s $770-million anti-diabetes drug, has been the only one to have a patent approval in India. The $24.2-billion company has fresh plans to aggressively file patents and have a localized pricing strategy for such drugs in order to scale up its impact in the Indian market.

The strategy is in line with Merck’s game plan to corner at least a 4% market share in India and emerge as one the top five players in the country by 2015.

MSD Pharma is a wholly owned subsidiary of Merck & Co in India. Its director (marketing) Sanjiv Navangul said, “We have received patent approval for two more drugs in India which are in advanced Phase III trials. We soon expect to launch them here. However, we will have a competitive and right pricing for all our patented drugs based on comprehensive research.”

The company’s right-pricing strategy involves a review of existing therapeutic alternatives for the patented drug and will also take the view of doctors and patients. “We have done similar research for Januvia which has been recently launched. We had consulted 200 doctors and patient groups to come to a right price for the drug in India,” said Mr. Navangul.

Page 1 Page 1 | 2  Next
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
X

Medwonders Health Network

  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
Obesity
Complete Medindia Resources
News Categories:  
Kidney Health Center

Drug Related News

» Schizophrenia Drug Differentiates Cancer Stem Cells into Less Threatening Cells » Docs Who Seldom Meet Drug Reps Continue to Prescribe Drugs With FDA “Black Box” Warnings
» Revision in Quality Standards for Heparin » Acne Drug Users At High Risk of Developing Eye Infections
» Patients Who Take Antidepressants When in ICU More Likely to Die » New Tablet Coating Product by Ideal Cures, In Geneva
» Prednisolone Benefits Patients With Bell's Palsy » 'Orphan' Sleep Drug may Fight Cancer
Read More >>